Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 6/20 | 0.65 |
| ▸ | NPBWR1 | P48145 | 5/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.57 |
| ▸ | GLP1R | P43220 | 5/20 | 0.57 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.56 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30637763 | 0.97 | RXFP1 (0.61) | RXFP1NPBWR1IL23RGLP1RECE1 | |
| SCHEMBL30598172 | 0.96 | RXFP1 (0.63) | RXFP1NPBWR1IL23RGLP1RECE1 | |
| SCHEMBL30578571 | 0.95 | RXFP1 (0.58) | RXFP1NPBWR1IL23RGLP1RECE1 | |
| SCHEMBL30874393 | 0.93 | RXFP1 (0.60) | RXFP1NPBWR1IL23RGLP1RECE1 | |
| SCHEMBL30627035 | 0.93 | RXFP1 (0.66) | RXFP1NPBWR1IL23RGLP1RECE1 | |
| SCHEMBL30874386 | 0.92 | RXFP1 (0.58) | RXFP1NPBWR1IL23RGLP1RECE1 | |
| SCHEMBL29396822 | 0.91 | NPBWR1 (0.61) | RXFP1NPBWR1IL23RPTH1R | |
| SCHEMBL30183209 | 0.91 | RXFP1 (0.68) | RXFP1NPBWR1GLP1RECE1MUS81 | |
| SCHEMBL30271992 | 0.91 | RXFP1 (0.68) | RXFP1NPBWR1GLP1RECE1MUS81 | |
| SCHEMBL31087271 | 0.91 | RXFP1 (0.68) | RXFP1NPBWR1GLP1RECE1MUS81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025032025-A1 | STABLE GLASSY MATERIAL BASED ON HISTIDINE, ARGININE AND GLUTAMIC ACID AMINO ACIDS | VITROPEP (FR) | 2025-02-13 | — | — | WO | disclosed |